Computational analysis reveals threonine ladder behavior varies with β-solenoid scaffolds, suggesting implications for novel antifreeze proteins.
Cold-adapted organisms frequently express antifreeze proteins (AFPs) that facilitate their survival at low temperatures, with some especially potent insect AFPs exhibiting β-solenoid structures with ice-binding threonine ladders. β-solenoids exist in nature in numerous forms and emerging protein design technologies may afford opportunities to diversify them further, suggesting the possibility of developing a variety of new AFPs by installing a threonine ladder on non-AFP natural or designed β-solenoids. However, early attempts at such engineering, combined with differences observed between AFPs and structurally similar ice-nucleating proteins, have raised a critical question: Will a threonine ladder show essentially the same behavior regardless of the β-solenoid scaffold that hosts it, or does the specific solenoid scaffold significantly affect a threonine ladder's structural characteristics (and thus potentially alter its suitability for ice binding)? We set out to address this question by creating distinct variants of a simplified model β-solenoid for in silico analysis via structure prediction and molecular dynamics simulations. Our findings indicate that local structural details such as the distance between the hydroxyl groups of adjacent threonines in a TXT motif can vary depending on the β-solenoid scaffold. In the most extreme example among our model solenoids, we observed in simulations that differences in only inward-facing residues of the scaffold were sufficient to influence the presence of ordered channel waters between the threonines, a noted feature of natural ice-binding threonine surfaces such as that of TmAFP. While additional studies will be necessary to expand on how such distinctions affect activity, these results emphasize that the impact of a particular β-solenoid scaffold on the local geometry of a threonine ladder may be a pertinent consideration in future efforts to design novel hyperactive AFPs to support applications ranging from biomedical cryopreservation to food science. We conclude our present investigation with a preliminary exploration of how this and other considerations manifest in a proposed workflow for generating predicted AFP-like β-solenoids using AlphaFold and ProteinMPNN.
No takes yet. Share an insight, caveat, or question.
Calia et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: